Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Monique French, MPH, Senior Director, Patient Advocacy, Health Policy & Communications, Rx4Good provides insight on engaging multiple healthcare groups. 

PAP 2024: Monique French Discusses Effective Ways to Engage Patients, Caregivers, and Advocacy Groups

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the important and often missing element in strategic planning for clinical-stage companies—and ways to close that focus gap.

Emerging Biopharma: Striving for Optimal Commercial Positioning

Articles

The latest news for pharma industry insiders.

Pharma Pulse 3/20/24: The DSCSA and the New Importation Policy in Florida, How Secure IS an Airplane’s Wi-Fi? & more

In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling. 

PAP 2024: Michael Galarraga Discusses "The State of Patient Access and Affordability” 

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.

PAP 2024: Examining Patient Access and Affordability

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments. 

PAP 2024: John Hoffman Discusses the Health Equity Spotlight Panel

Conference’s opening session addresses the evolving landscape of healthcare coverage and accessibility.

Access USA 2024: The State of the Industry

The FDA previously granted priority review to a biologics license application for V116 as a single dose for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.

Merck's 21-Valent Pneumococcal Conjugate Vaccine Shows Efficacy Across Various Serotypes

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, talks about the challenging environment today for emerging biopharma companies in demonstrating the value of their promising early-stage drug candidates to potential investors or buyers.

News